Watch VideoAnother drugmaker is sharing the data that their COVID vaccine works. In clinical trials of more than 43,000 people, Johnson & Johnson’s one dose shot was 66% effective at preventing moderate to severe disease 28 days after vaccination.
“We haven't really done a good job, I think, of explaining to the public...
Study: J&J COVID-19 Vaccine 72% Effective in U.S.
Newsy
0 shares
1 views
You might like
Related news coverage
A Third Of Americans say Unlikely Or Hesitant To Get COVID-19 Vaccine
Eurasia Review
News reports indicate COVID-19 vaccines are not getting out soon enough nor in adequate supplies to most regions, but there may be..
-
Novavax Covid vaccine news welcomed in South Africa
IndiaTimes
-
News24.com | Covid-19 vaccines may need adjusting to new strains, scientists say
News24
-
One-shot vaccine proves effective, says Johnson & Johnson
Japan Today
-
'Game changer' single-dose vaccine from Johnson & Johnson is safe and 66% effective, company says
Upworthy
Advertisement
More coverage
Novavax spikes 67% after UK study shows its COVID-19 vaccine is 89% effective
Business Insider
Shares of Novavax soared more than 2,700% since the company advanced the development of its novel COVID-19 vaccine candidate in..
-
Single-shot Johnson & Johnson vaccine 66 per cent effective against COVID-19, study shows
Brisbane Times
-
J&J 1-dose shot prevents COVID-19, but less than some others
SeattlePI.com
-
Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa
bizjournals
-
Novavax COVID-19 Vaccine Works, But Less So Against Variants
VOA News